HOSPITAL WILMA N VAZQUEZ
1. Target Overview & Investment Thesis
HOSPITAL WILMA N VAZQUEZ is a 100-bed safety-net/medicaid heavy in nan, PR with $37.6M in net patient revenue and a 5.6% operating margin. The hospital serves a payer mix of 5.9% Medicare, 36.6% Medicaid, and 57.5% commercial.
Thesis: Turnaround. Our ML models identify $2.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.6% to 12.9% (+736bps).
| Net Revenue HCRIS | $37.6M |
| Current EBITDA COMPUTED | $2.1M |
| Operating Margin COMPUTED | 5.6% |
| Occupancy HCRIS | 54.8% |
| Revenue / Bed COMPUTED | $376K |
| Net-to-Gross HCRIS | 38.5% |
| Distress Probability ML | 56.3% |
2. Market Context & Competitive Position
PR has 61 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of 5.6% places it above the state median. Among 36 size-comparable peers (50-200 beds), the median margin is -12.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (50-200), prioritizing same-state peers. 36 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HOSPITAL WILMA N VAZQUEZ (Target) | PR | 100 | $37.6M | 5.6% |
| ADMIN DE SERVICIOS MEDICOS DE | PR | 65 | $179.7M | -50.0% |
| HOSPITAL PAVIA SANTURCE | PR | 156 | $101.9M | -9.4% |
| HOSPITAL MENONITA AIBONITO | PR | 129 | $92.1M | -3.1% |
| HOSPITAL DE LA CONCEPCION | PR | 167 | $91.0M | -3.9% |
| CORPORACION DEL CENTRO CARDIOV | PR | 164 | $77.2M | -14.2% |
| HOSPITAL MENONITA GUAYAMA | PR | 134 | $73.2M | 19.4% |
| ASHFORD PRESBYTERIAN COMMUNITY | PR | 152 | $63.5M | -13.8% |
| HOSPITAL DAMAS | PR | 128 | $59.6M | -21.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $790K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $752K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $745K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $458K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $24K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $2.1M |
| + RCM Uplift | +$2.8M |
| Pro Forma EBITDA | $4.9M |
| Current Margin | 5.6% |
| Pro Forma Margin | 12.9% |
| WC Released (1x) | $1.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $3.2M | $41.5M | 12.88x | 66.7% |
| Base (11x exit) | 10.0x | 11.0x | $3.2M | $46.7M | 14.49x | 70.7% |
| Bull Case | 9.0x | 11.0x | $2.9M | $56.9M | 19.61x | 81.3% |
| Bull (12x exit) | 9.0x | 12.0x | $2.9M | $62.9M | 21.69x | 85.0% |
| Bear Case | 11.0x | 10.0x | $3.5M | $26.6M | 7.51x | 49.6% |
| Bear (11x exit) | 11.0x | 11.0x | $3.5M | $30.4M | 8.58x | 53.7% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Elevated Medicaid exposure (36.6%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 56.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 36 hospitals with 50-200 beds
- Same-state prioritization (n=37)
- Comp margins: P25=-21.4% / P50=-12.4% / P75=-4.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.